Form 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 27, 2010
Commission file number 000-49602
SYNAPTICS INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
77-0118518 |
|
|
|
(State or other jurisdiction
|
|
(I.R.S. Employer |
of incorporation or organization)
|
|
Identification No.) |
3120 Scott Blvd.
Santa Clara, California
95054
(Address of principal executive offices)
(Zip code)
(408) 454-5100
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act.
(Check one):
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
Number of shares of Common Stock outstanding at April 27, 2010: 33,874,001
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2010
TABLE OF CONTENTS
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
June 30, |
|
|
|
2010 |
|
|
2009* |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
168,665 |
|
|
$ |
169,036 |
|
Short-term investments |
|
|
|
|
|
|
22,934 |
|
Accounts receivable, net of allowances of $513
at March 31, 2010 and June 30, 2009 |
|
|
87,992 |
|
|
|
84,739 |
|
Inventories |
|
|
18,208 |
|
|
|
14,950 |
|
Prepaid expenses and other current assets |
|
|
3,723 |
|
|
|
3,094 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
278,588 |
|
|
|
294,753 |
|
Property and equipment at cost, net of accumulated depreciation of $17,970
and $11,712 at March 31, 2010 and June 30, 2009, respectively |
|
|
25,378 |
|
|
|
25,431 |
|
Goodwill |
|
|
1,927 |
|
|
|
1,927 |
|
Non-current investments |
|
|
28,816 |
|
|
|
28,767 |
|
Other assets |
|
|
20,494 |
|
|
|
25,272 |
|
|
|
|
|
|
|
|
|
|
$ |
355,203 |
|
|
$ |
376,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
48,204 |
|
|
$ |
32,210 |
|
Accrued compensation |
|
|
10,284 |
|
|
|
8,450 |
|
Income taxes payable |
|
|
7,928 |
|
|
|
9,128 |
|
Current deferred tax liabilities |
|
|
|
|
|
|
10,225 |
|
Other accrued liabilities |
|
|
15,483 |
|
|
|
11,813 |
|
Notes payable |
|
|
|
|
|
|
63,234 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
81,899 |
|
|
|
135,060 |
|
|
|
|
|
|
|
|
Convertible senior subordinated notes |
|
|
2,305 |
|
|
|
|
|
Other liabilities |
|
|
18,553 |
|
|
|
18,484 |
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Common stock: |
|
|
|
|
|
|
|
|
$0.001 par value; 60,000,000 shares authorized; 44,461,849 and
43,779,011 shares issued, and 33,590,536 and 34,690,911 shares
outstanding, at March 31, 2010 and June 30, 2009, respectively |
|
|
44 |
|
|
|
44 |
|
Additional paid-in capital |
|
|
332,839 |
|
|
|
293,666 |
|
Less: 10,871,313 and 9,088,100 common treasury shares at
March 31, 2010 and June 30, 2009, respectively, at cost |
|
|
(281,932 |
) |
|
|
(237,387 |
) |
Accumulated other comprehensive income |
|
|
1,704 |
|
|
|
129 |
|
Retained earnings |
|
|
199,791 |
|
|
|
166,154 |
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
252,446 |
|
|
|
222,606 |
|
|
|
|
|
|
|
|
|
|
$ |
355,203 |
|
|
$ |
376,150 |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Reflects the retrospective application of the new accounting pronouncement applicable to
convertible debt instruments that can be settled in cash. See notes 1 and 8. |
See notes to condensed consolidated financial statements (unaudited).
3
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009* |
|
|
2010 |
|
|
2009* |
|
|
Net revenue |
|
$ |
116,212 |
|
|
$ |
100,595 |
|
|
$ |
369,127 |
|
|
$ |
357,975 |
|
Cost of revenue |
|
|
68,910 |
|
|
|
59,888 |
|
|
|
219,672 |
|
|
|
212,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
47,302 |
|
|
|
40,707 |
|
|
|
149,455 |
|
|
|
145,106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
21,212 |
|
|
|
17,286 |
|
|
|
63,629 |
|
|
|
49,031 |
|
Selling, general, and administrative |
|
|
14,635 |
|
|
|
12,786 |
|
|
|
44,974 |
|
|
|
41,070 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
35,847 |
|
|
|
30,072 |
|
|
|
108,603 |
|
|
|
90,101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
11,455 |
|
|
|
10,635 |
|
|
|
40,852 |
|
|
|
55,005 |
|
Interest income |
|
|
200 |
|
|
|
538 |
|
|
|
772 |
|
|
|
2,770 |
|
Interest expense |
|
|
(4 |
) |
|
|
(1,374 |
) |
|
|
(2,395 |
) |
|
|
(5,654 |
) |
Loss on early retirement of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,053 |
) |
Impairment of investments, net |
|
|
|
|
|
|
(2,894 |
) |
|
|
(443 |
) |
|
|
(9,403 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
11,651 |
|
|
|
6,905 |
|
|
|
38,786 |
|
|
|
41,665 |
|
Provision for income taxes |
|
|
45 |
|
|
|
1,499 |
|
|
|
5,149 |
|
|
|
5,973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
11,606 |
|
|
$ |
5,406 |
|
|
$ |
33,637 |
|
|
$ |
35,692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.35 |
|
|
$ |
0.16 |
|
|
$ |
0.99 |
|
|
$ |
1.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
$ |
0.33 |
|
|
$ |
0.15 |
|
|
$ |
0.95 |
|
|
$ |
1.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
33,526 |
|
|
|
34,062 |
|
|
|
33,826 |
|
|
|
33,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
35,095 |
|
|
|
35,243 |
|
|
|
35,371 |
|
|
|
35,291 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Reflects the retrospective application of the new accounting pronouncement applicable to
convertible debt instruments that can be settled in cash. See notes 1 and 8. |
See notes to condensed consolidated financial statements (unaudited).
4
SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
|
2010 |
|
|
2009* |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
33,637 |
|
|
$ |
35,692 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
Share-based compensation costs |
|
|
27,339 |
|
|
|
17,640 |
|
Deferred taxes |
|
|
(3,137 |
) |
|
|
(9,571 |
) |
Tax benefit realized from share-based compensation |
|
|
5,294 |
|
|
|
6,052 |
|
Excess tax benefit from share-based compensation |
|
|
(5,294 |
) |
|
|
(6,052 |
) |
Depreciation of property and equipment |
|
|
6,320 |
|
|
|
4,458 |
|
Amortization of debt issuance costs |
|
|
118 |
|
|
|
298 |
|
Impairment of investments, net |
|
|
443 |
|
|
|
9,403 |
|
Amortization of debt discount |
|
|
2,069 |
|
|
|
4,817 |
|
Loss on early retirement of debt |
|
|
|
|
|
|
1,053 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
|
(3,253 |
) |
|
|
199 |
|
Inventories |
|
|
(3,258 |
) |
|
|
5,206 |
|
Prepaid expenses and other current assets |
|
|
168 |
|
|
|
(586 |
) |
Other assets |
|
|
(3,259 |
) |
|
|
(4,618 |
) |
Accounts payable |
|
|
15,994 |
|
|
|
4,110 |
|
Accrued compensation |
|
|
1,834 |
|
|
|
222 |
|
Income taxes |
|
|
(1,176 |
) |
|
|
3,995 |
|
Other accrued liabilities |
|
|
3,715 |
|
|
|
3,102 |
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
77,554 |
|
|
|
75,420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
(5,986 |
) |
|
|
(21,012 |
) |
Proceeds from sales and maturities of short-term investments |
|
|
28,912 |
|
|
|
42,913 |
|
Proceeds from sales and maturities of non current investments |
|
|
1,125 |
|
|
|
1,625 |
|
Purchases of property and equipment |
|
|
(6,267 |
) |
|
|
(7,289 |
) |
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
17,784 |
|
|
|
16,237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Purchases of treasury stock |
|
|
(44,545 |
) |
|
|
|
|
Proceeds from issuance of common stock upon exercise of options
and stock purchase plan |
|
|
8,148 |
|
|
|
9,105 |
|
Retirement of debt, net of discount |
|
|
(62,998 |
) |
|
|
(55,656 |
) |
Excess tax benefit from share-based compensation |
|
|
5,294 |
|
|
|
6,052 |
|
Payroll taxes for deferred stock units |
|
|
(1,608 |
) |
|
|
(1,296 |
) |
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(95,709 |
) |
|
|
(41,795 |
) |
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents |
|
|
(371 |
) |
|
|
49,862 |
|
Cash and cash equivalents at beginning of period |
|
|
169,036 |
|
|
|
96,218 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
168,665 |
|
|
$ |
146,080 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information |
|
|
|
|
|
|
|
|
Cash paid for income taxes |
|
$ |
11,342 |
|
|
$ |
5,507 |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Reflects the retrospective application of the new accounting pronouncement
applicable to convertible debt instruments that can be settled in cash. See
notes 1 and 8. |
See notes to condensed consolidated financial statements (unaudited).
5
SYNAPTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared
pursuant to the rules and regulations of the Securities and Exchange Commission (the SEC) and
U.S. generally accepted accounting principles (U.S. GAAP). However, certain information or
footnote disclosures normally included in financial statements prepared in accordance with U.S.
GAAP have been condensed or omitted pursuant to such SEC rules and regulations. In our opinion,
the financial statements include all adjustments, which are of a normal and recurring nature,
necessary for the fair presentation of the results of the interim periods presented. The results
of operations for the interim periods are not necessarily indicative of the operating results for
the full fiscal year or any future period. These financial statements should be read in
conjunction with the audited consolidated financial statements and related notes included in our
annual report on Form 10-K for the fiscal year ended June 30, 2009.
The consolidated financial statements include our financial statements and those of our wholly
owned subsidiaries. All significant intercompany balances and transactions have been eliminated
upon consolidation.
Our fiscal year is the 52- or 53-week period ending on the last Saturday in June. Our fiscal
2010 will be a 52-week period ending on June 26, 2010. Our fiscal 2009 was a 52-week period ending
on June 27, 2009. The fiscal periods presented in this report were 13-week and 39-week periods for
the three and nine months ended March 27, 2010 and March 28, 2009. For ease of presentation, the
accompanying consolidated financial statements have been shown as ending on March 31 and calendar
quarter end dates for all annual, interim, and quarterly financial statement captions, unless
otherwise indicated.
Stock Split
On July 31, 2008, we announced a 3-for-2 stock split to be effected as a stock dividend. The
stock dividend was effective for stockholders of record on August 15, 2008 and was paid on August
29, 2008. All share and per share amounts contained herein reflect the stock split, except for
treasury shares.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires us
to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue,
expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we
evaluate our estimates, including those related to revenue recognition, allowance for doubtful
accounts, cost of revenue, inventories, product warranty, share-based compensation costs, provision
for income taxes, income taxes payable, investments, and contingencies. We base our estimates on
historical experience, applicable laws and regulations, and various other assumptions that we
believe to be reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying value of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different assumptions or
conditions.
Retrospective application of ASC 470-20
On July 1, 2009, we adopted ASC 470-20, formerly known as FSP APB 14-1, Accounting for
Convertible Debt Instruments That May Be Settled in Cash upon Conversion. This standard applies
to our 0.75% Convertible Senior Subordinated Notes (the Notes). The adoption of this accounting
standard, which must be applied on a retrospective basis, resulted in a non-cash interest charge
for all periods presented in our financial statements during which the Notes were outstanding.
Upon adoption of the new standard, and effective as of the issuance date of the Notes, we
recorded $39.4 million of the principal amount to equity, representing the debt discount for the
difference between our estimated nonconvertible debt borrowing rate of 8.5% at the time of issuance
and the 0.75% coupon rate of the Notes using a five-year life, which coincides with the initial put
rights of the Noteholders. In addition, we allocated the $4.3 million of debt issuance costs
pro-rata to the equity and debt components of the Notes, or $1.4 million and $2.9 million,
respectively. The debt discount and the debt issuance costs allocated to the debt component were
amortized as interest expense using the effective interest method over five years, which were fully
amortized as of December 31, 2009.
6
Immaterial Correction of an Error
During the quarter ended March 31, 2010, we corrected an error in the amount of $1.8 million
to increase our income tax benefit as a result of carrying back our prior year net operating loss.
The adjustment to income tax benefit should have been recognized during our fiscal years 2008 and
2009 in the amount of $960,000 and $855,000, respectively. The impact of the correction resulted
in a decrease in the provision for income taxes and a corresponding increase in net income of $1.8
million during the three and nine months ended March 31, 2010.
Based upon an evaluation of all relevant quantitative and qualitative factors, and after
considering the provisions of the relevant accounting guidance, we do not believe that the impact
of this error is material to our consolidated financial statements for the three and nine months
ended March 31, 2010 and for fiscal years 2008 and 2009. Accordingly, the correction has been
reflected in our condensed consolidated financial statements during the third quarter of fiscal
2010.
2. Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement
exists, delivery has occurred and title has transferred, the price is fixed or determinable, and
collection is reasonably assured. We accrue for estimated sales returns and other allowances,
based on historical experience, at the time we recognize revenue. We record contract revenue for
research and development as we provide the services under the terms of the contract. We recognize
non-refundable contract fees for which no further performance obligations exist and for which there
is no continuing involvement by us on the earlier of when the payments are received or when
collection is assured.
3. Net Income Per Share
We present basic and diluted net income per share amounts in conformity with U.S. GAAP for all
periods presented. The following table presents the computation of basic and diluted net income per
share (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009* |
|
|
2010 |
|
|
2009* |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
11,606 |
|
|
$ |
5,406 |
|
|
$ |
33,637 |
|
|
$ |
35,692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares, basic |
|
|
33,526 |
|
|
|
34,062 |
|
|
|
33,826 |
|
|
|
33,845 |
|
Effect of dilutive share-based awards |
|
|
1,569 |
|
|
|
1,181 |
|
|
|
1,545 |
|
|
|
1,446 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares, diluted |
|
|
35,095 |
|
|
|
35,243 |
|
|
|
35,371 |
|
|
|
35,291 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.35 |
|
|
$ |
0.16 |
|
|
$ |
0.99 |
|
|
$ |
1.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
$ |
0.33 |
|
|
$ |
0.15 |
|
|
$ |
0.95 |
|
|
$ |
1.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Reflects the retrospective application of the new accounting pronouncement applicable to
convertible debt instruments that can be settled in cash. See notes 1 and 8. |
Our basic net income per share amounts for each period presented have been computed using the
weighted average number of shares of common stock outstanding. Our diluted net income per share
amounts for each period presented include the weighted average effect of potentially dilutive
shares. We use the treasury stock method to determine the dilutive effect of our share-based
awards and Notes. No shares associated with our Notes were included in dilutive shares for the
periods presented as the weighted average share price during each period was less than the
conversion price of $33.69.
Dilutive net income per share amounts do not include the weighted average effect of 3,778,523
and 3,351,754 share-based awards that were outstanding during the three months ended March 31, 2010
and 2009, respectively, and 3,614,277 and 2,635,899 share-based awards that were outstanding during
the nine months ended March 31, 2010 and 2009, respectively. These share-based awards were not
included in the computation of diluted net income per share because the proceeds received, if any,
from such share-based awards combined with the average unamortized compensation costs adjusted for
the hypothetical tax benefit or deficiency creditable or chargeable, respectively, to additional
paid-in capital, were greater than the average market price of our common stock, and therefore,
their effect would have been antidilutive.
7
4. Cash Equivalents, Short-Term Investments, and Auction Rate Securities Investments
Cash equivalents consist of highly liquid investments with original maturities of three months
or less. Short-term investments consist of marketable securities and are classified as securities
available for sale in accordance with U.S. GAAP. Included in our non-current investments are
auction rate securities, or ARS. Our short-term and non-current investments are reported at fair
value, with unrealized gains and losses excluded from earnings and are shown separately as a
component of accumulated other comprehensive income within stockholders equity. We charge an
other-than-temporary decline in the fair value of a debt security to earnings if the decline
results from a credit loss or to other comprehensive income if the decline results from a noncredit
loss, resulting in the establishment of a new cost basis for the debt security. We charge
other-than-temporary declines in the fair value of equity securities to earnings. We include
interest earned on marketable securities in interest income. We determine realized gains and
losses on the sale of marketable securities using the specific identification method.
Our ARS investments, which have a par value of $41.4 million, have failed to settle in
auctions beginning in September 2007. These investments are not liquid, and in the event we need
to access these funds, we will not be able to do so without a loss of principal, unless redeemed by
the issuers or a future auction on these investments is successful. During the three and nine
months ended March 31, 2010, we recognized a gain of zero and $6,000 on the redemption at par of
$125,000 and $1.1 million, respectively, of our ARS investments. During the three and nine months
ended March 31, 2009, zero and $1.6 million, respectively, of our ARS investments were redeemed at
par, and there was no associated gain or loss on the redemption of these investments.
As there are currently no active markets for our various failed ARS investments, we have
estimated the fair value as of March 31, 2010 using a trinomial discounted cash flow analysis. The
analysis considered, among other factors:
|
|
|
the collateral underlying the security investments; |
|
|
|
creditworthiness of the counterparty; |
|
|
|
timing of expected future cash flows; |
|
|
|
the probability of a successful auction in a future period; |
|
|
|
the underlying structure of each investment; |
|
|
|
the present value of future principal and interest payments discounted at rates
considered to reflect current market conditions; |
|
|
|
consideration of the probabilities of default, passing a future auction, or redemption
at par for each period; and |
|
|
|
estimates of the recovery rates in the event of default for each investment. |
When possible, our failed ARS investments were compared to other observable market data or
securities with similar characteristics. Our estimate of the fair value of our ARS investments
could change materially from period to period based on future market conditions.
Contractual maturities for our ARS investments are generally greater than five years, with
fair value of $9.6 million maturing from 2015 to 2017, $9.0 million maturing from 2034 to 2045, and
$10.2 million maturing thereafter or having no stated maturity. Of our ARS investments, $22.9
million par value are investment grade, and the remaining $18.5 million par value are below
investment grade. In connection with our fair value analysis for the nine-month periods ended
March 31, 2010 and 2009, we recorded a $449,000 and $9.4 million, respectively,
other-than-temporary impairment charges on our ARS investments in preferred stock.
8
The following table sets forth the types of ARS investments we held as of March 31, 2010,
including the original cost basis, other-than-temporary impairment included in other comprehensive
income, other-than-temporary impairment included in retained earnings, new cost basis, unrealized
gain, and fair value (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Other-than- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
temporary Impairment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included |
|
|
Included |
|
|
|
|
|
|
|
|
|
|
|
|
Original |
|
|
in Other |
|
|
in |
|
|
New |
|
|
|
|
|
|
|
|
|
Cost |
|
|
Comprehensive |
|
|
Retained |
|
|
Cost |
|
|
Unrealized |
|
|
Fair |
|
|
|
Basis |
|
|
Income |
|
|
Earnings |
|
|
Basis |
|
|
Gain |
|
|
Value |
|
Student loans |
|
$ |
9,650 |
|
|
$ |
624 |
|
|
$ |
262 |
|
|
$ |
8,764 |
|
|
$ |
242 |
|
|
$ |
9,006 |
|
Closed end municipal
and corporate funds |
|
|
11,200 |
|
|
|
1,164 |
|
|
|
93 |
|
|
|
9,943 |
|
|
|
274 |
|
|
|
10,217 |
|
Credit linked notes |
|
|
13,500 |
|
|
|
155 |
|
|
|
8,765 |
|
|
|
4,580 |
|
|
|
3,182 |
|
|
|
7,762 |
|
Preferred stock |
|
|
5,000 |
|
|
|
|
|
|
|
5,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Municipals |
|
|
2,000 |
|
|
|
203 |
|
|
|
83 |
|
|
|
1,714 |
|
|
|
117 |
|
|
|
1,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total ARS |
|
$ |
41,350 |
|
|
$ |
2,146 |
|
|
$ |
14,203 |
|
|
$ |
25,001 |
|
|
$ |
3,815 |
|
|
$ |
28,816 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth the types of ARS investments we held as of June 30, 2009,
including the original cost basis, other-than-temporary impairment included in other comprehensive
income, other-than-temporary impairment included in retained earnings, new cost basis, unrealized
gain, and fair value (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Other-than- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
temporary Impairment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included |
|
|
Included |
|
|
|
|
|
|
|
|
|
|
|
|
Original |
|
|
in Other |
|
|
in |
|
|
New |
|
|
|
|
|
|
|
|
|
Cost |
|
|
Comprehensive |
|
|
Retained |
|
|
Cost |
|
|
Unrealized |
|
|
Fair |
|
|
|
Basis |
|
|
Income |
|
|
Earnings |
|
|
Basis |
|
|
Gain |
|
|
Value |
|
Student loans |
|
$ |
9,900 |
|
|
$ |
642 |
|
|
$ |
262 |
|
|
$ |
8,996 |
|
|
$ |
239 |
|
|
$ |
9,235 |
|
Closed end municipal
and corporate funds |
|
|
12,075 |
|
|
|
1,256 |
|
|
|
99 |
|
|
|
10,720 |
|
|
|
239 |
|
|
|
10,959 |
|
Credit linked notes |
|
|
13,500 |
|
|
|
156 |
|
|
|
8,765 |
|
|
|
4,579 |
|
|
|
1,774 |
|
|
|
6,353 |
|
Preferred stock |
|
|
5,000 |
|
|
|
|
|
|
|
4,551 |
|
|
|
449 |
|
|
|
|
|
|
|
449 |
|
Municipals |
|
|
2,000 |
|
|
|
203 |
|
|
|
83 |
|
|
|
1,714 |
|
|
|
57 |
|
|
|
1,771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total ARS |
|
$ |
42,475 |
|
|
$ |
2,257 |
|
|
$ |
13,760 |
|
|
$ |
26,458 |
|
|
$ |
2,309 |
|
|
$ |
28,767 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We have accounted for all of our ARS investments as non-current as we are not able to
reasonably determine when the ARS markets will recover or be restructured. Based on our ability to
access our cash, our expected operating cash flows, and our other sources of cash, we have the
intent and ability to hold these investments until the value recovers or the investments mature.
We will continue to monitor our ARS investments in light of the current debt market environment and
evaluate our accounting for these investments quarterly. Subsequent to recording
other-than-temporary impairment charges, certain of our ARS investments have increased in value
above their new cost bases, and this increase is included as unrealized gain above and in
accumulated other comprehensive income in the accompanying consolidated balance sheet.
5. Fair Value of Cash Equivalents and Investments
Effective the beginning of fiscal 2009, we adopted the fair value option for financial assets
and liabilities recognized or disclosed at fair value on a recurring basis. For other financial
assets and liabilities which are not recognized or disclosed at fair value on a recurring basis, we
elected not to apply the fair value option. Effective the beginning of fiscal 2010, we adopted the
fair value option for non-financial assets and liabilities. The adoption of the fair value option
for non-financial assets and liabilities did not have a material impact on our consolidated
financial position, results of operations, or cash flows.
9
Current accounting standards establish a consistent framework for measuring fair value on
either a recurring or nonrecurring basis in which inputs, used in valuation techniques, are
assigned a hierarchical level.
The following are the hierarchical levels of inputs to measure fair value:
|
|
|
Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets
or liabilities in active markets. |
|
|
|
Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets
that are not active; quoted prices for similar assets or liabilities in active markets;
inputs other than quoted prices that are observable for the assets or liabilities; or
inputs that are derived principally from or corroborated by observable market data by
correlation or other means. |
|
|
|
Level 3: Unobservable inputs reflecting our own assumptions incorporated in valuation
techniques used to determine fair value. These assumptions must be consistent with market
participant assumptions that are reasonably available. Our Level 3 assets consist of
long-term ARS investments. We estimated the fair value of
our ARS investments based on the following: (i) the underlying structure of each
investment; (ii) the present value of future principal and interest payments discounted at
rates considered to reflect current market conditions; (iii) consideration of the
probabilities of default, passing a future auction, or repurchase at par for each period;
and (iv) estimates of the recovery rates in the event of default for each investment. |
The following table summarizes our financial assets and liabilities measured at fair value on
a recurring basis, by level within the fair value hierarchy, as of March 31, 2010 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
|
Level 3 |
|
|
|
|
|
|
|
|
|
|
Money market |
|
$ |
166,732 |
|
|
$ |
|
|
Auction rate securities |
|
|
|
|
|
|
28,816 |
|
|
|
|
|
|
|
|
Total available-for-sale securities |
|
$ |
166,732 |
|
|
$ |
28,816 |
|
|
|
|
|
|
|
|
Money market balances are included in cash and cash equivalents as of March 31, 2010. ARS are
included in non-current investments as of March 31, 2010.
The following table summarizes our financial assets and liabilities measured at fair value on
a recurring basis, by level within the fair value hierarchy, as of June 30, 2009 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2009 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market |
|
$ |
166,334 |
|
|
$ |
|
|
|
$ |
|
|
Commercial paper |
|
|
|
|
|
|
2,598 |
|
|
|
|
|
U.S. Treasury bills |
|
|
|
|
|
|
7,995 |
|
|
|
|
|
Municipal securities |
|
|
|
|
|
|
12,941 |
|
|
|
|
|
Auction rate securities |
|
|
|
|
|
|
|
|
|
|
28,767 |
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities |
|
$ |
166,334 |
|
|
$ |
23,534 |
|
|
$ |
28,767 |
|
|
|
|
|
|
|
|
|
|
|
Money market balances are included in cash and cash equivalents as of June 30, 2009.
Commercial paper, U.S. Treasury bills, and municipal securities are included in cash and cash
equivalents and short-term investments as of June 30, 2009. ARS are included in non-current
investments as of June 30, 2009.
10
The following table provides a summary of changes in fair value of our Level 3 financial
assets as of March 31, 2010 (in thousands):
|
|
|
|
|
Balance as of June 30, 2009 |
|
$ |
28,767 |
|
Net change in other comprehensive
income from Level 3 financial assets |
|
|
1,617 |
|
Other than temporary impairment, net |
|
|
(443 |
) |
Redemptions |
|
|
(1,125 |
) |
|
|
|
|
Balance as of March 31, 2010 |
|
$ |
28,816 |
|
|
|
|
|
The following table provides a summary of changes in fair value of our Level 3 financial
assets as of March 31, 2009 (in thousands):
|
|
|
|
|
Balance as of June 30, 2008 |
|
$ |
37,946 |
|
Net change in other comprehensive
income from Level 3 financial assets |
|
|
2,993 |
|
Other than temporary impairment, net |
|
|
(9,403 |
) |
Redemptions |
|
|
(1,625 |
) |
|
|
|
|
Balance as of March 31, 2009 |
|
$ |
29,911 |
|
|
|
|
|
There were no transfers in or out of our Level 1, 2 or 3 assets during the nine months ended
March 31, 2010 and March 31, 2009.
The fair values of our cash equivalents, accounts receivable, accounts payable, and accrued
liabilities approximate their carrying values because of the short-term nature of those
instruments. We base the fair value of short-term investments on current trading values and the
fair value of our ARS on a trinomial discounted cash flow model.
6. Inventories
Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated
net realizable value) and consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
June 30, |
|
|
|
2010 |
|
|
2009 |
|
Raw materials |
|
$ |
12,975 |
|
|
$ |
9,217 |
|
Finished goods |
|
|
5,233 |
|
|
|
5,733 |
|
|
|
|
|
|
|
|
|
|
$ |
18,208 |
|
|
$ |
14,950 |
|
|
|
|
|
|
|
|
Periodically, we purchase inventory from our contract manufacturers when a customer delays its
delivery schedule or cancels its order. In those circumstances in which our customer has cancelled
its order and we purchase inventory from our contract manufacturers, we consider a write-down to
reduce the carrying value of the inventory purchased to its net realizable value. We charge
write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to net
realizable value to cost of revenue. The effect of these write-downs is to establish a new cost
basis in the related inventory, which we do not subsequently write up.
7. Product Warranties, Indemnifications, and Contingencies
Product Warranties
We generally warrant our products for a period of 12 months or more from the date of sale and
estimate probable product warranty costs at the time we recognize revenue. Factors that affect our
warranty liability include historical and anticipated rates of warranty claims, materials usage,
and service delivery costs. Warranty costs incurred have not been material in recent years.
However, we assess the adequacy of our warranty obligations periodically and adjust the accrued
warranty liability on the basis of our estimates.
11
Indemnifications
In connection with certain third-party agreements, we are obligated to indemnify the third
party in connection with any technology infringement by us. We have also entered into
indemnification agreements with our officers and directors. Maximum potential future payments
cannot be estimated because these agreements do not have a maximum stated liability. However,
historical costs related to these indemnification provisions have not been significant. We have
not recorded any liability in our consolidated financial statements for such indemnification
obligations.
Contingencies
We may receive notices from third parties that claim our products infringe their rights. From
time to time, we receive notice from third parties alleging infringement of their intellectual
property rights. We cannot be certain that our technologies and products do not or will not
infringe issued patents or other proprietary rights of third parties.
Any infringement claims, with or without merit, could result in significant litigation costs
and diversion of management and financial resources, including the payment of damages, which could
have a material adverse effect on our business, financial condition, and results of operations. In
October 2008, we entered into a settlement and cross-license agreement with a competitor, which
settled all disputes between the parties and granted each party irrevocable, non-transferable,
non-assignable, non-exclusive, worldwide rights to certain patents over their remaining lives. The
impact of the settlement was not material to our financial results and is not expected to have a
material impact on our future cash flows, results of operations, or financial position.
8. Convertible Senior Subordinated Notes
In December 2004, we issued an aggregate of $125 million of Notes maturing December 1, 2024 in
a private offering pursuant to Rule 144A under the Securities Act of 1933, as amended. In
connection with issuing the Notes, we incurred debt issuance costs of $4.3 million, consisting
primarily of the initial purchasers discount and costs related to legal, accounting, and printing,
which are being amortized over five years. We used the net proceeds for working capital and
general corporate purposes.
During the second quarter of fiscal 2009, we repurchased and retired $59.7 million of our
outstanding Notes at a discount from par of approximately 7%, which resulted in a $1.1 million net
loss on retirement of debt after deducting the associated unamortized debt discount and debt
issuance costs. In December 2009, we repurchased and retired $63.0 million par value of our Notes
when investors exercised their rights to require us to repurchase their Notes. Accordingly, as of
March 31, 2010, $2.3 million par value of our Notes remained outstanding and have been classified
as long-term as the next date Noteholders can require us to repurchase all or a portion of their
Notes is beyond one year.
Interest expense includes the amortization of debt discount and debt issuance costs. We
recorded $4,000 and $1.4 million of interest expense on the Notes during the three-month periods
ended March 31, 2010 and 2009, respectively. We recorded $2.4 million and $5.7 million of interest
expense on the Notes during the nine-month periods ended March 31, 2010 and 2009, respectively. As
of December 31, 2009, the amortization of the discount and debt issuance costs was complete, and
the if-converted value of the Notes did not exceed the principal amount of the Notes.
On July 1, 2009, we adopted ASC 470-20, which is the new accounting standard applicable to
convertible debt that can be settled in cash. The adoption of this accounting standard, which must
be applied on a retrospective basis, results in a non-cash interest charge for all periods
presented in our financial statements during which the Notes were outstanding. This standard
requires issuers of convertible notes that can be settled in cash to separately account for the
liability and equity components of such convertible notes in a manner that reflects the entitys
nonconvertible debt borrowing rate. Prior to the application of the standard, the liability of the
Notes was carried at their par value, and only the contractual interest and amortization of debt
issuance costs were recognized in our condensed consolidated statements of income.
Upon adoption of the new standard, and effective as of the issuance date of the Notes, we
recorded $39.4 million of the principal amount to equity, representing the debt discount for the
difference between our estimated nonconvertible debt borrowing rate of 8.5% at the time of issuance
and the 0.75% coupon rate of the Notes using a five-year life, which coincides with the initial put
rights of the Noteholders. In addition, we allocated the $4.3 million of debt issuance costs
pro-rata to the equity and debt components of the Notes, or $1.4 million and $2.9 million,
respectively. The debt discount and the debt issuance costs allocated to the debt component were
amortized as interest expense using the effective interest method over five years; which were fully
amortized as of December 31, 2009.
12
As of March 31, 2010 and June 30, 2009, the liability and equity components of the Notes
consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
June 30, |
|
|
|
2010 |
|
|
2009 |
|
Principal amount of outstanding Notes |
|
$ |
2,305 |
|
|
$ |
65,303 |
|
Unamortized discount |
|
|
|
|
|
|
2,069 |
|
|
|
|
|
|
|
|
Liability component of outstanding Notes, net |
|
$ |
2,305 |
|
|
$ |
63,234 |
|
|
|
|
|
|
|
|
|
Equity component of outstanding Notes |
|
$ |
727 |
|
|
$ |
20,591 |
|
The contractual interest expense and amortization of discount for the Notes for the three and
nine months ended March 31, 2010 and 2009 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
Interest expense |
|
$ |
4 |
|
|
$ |
123 |
|
|
$ |
208 |
|
|
$ |
539 |
|
Amortization of debt issuance costs |
|
|
|
|
|
|
70 |
|
|
|
118 |
|
|
|
298 |
|
Amortization of discount |
|
|
|
|
|
|
1,181 |
|
|
|
2,069 |
|
|
|
4,817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total interest |
|
$ |
4 |
|
|
$ |
1,374 |
|
|
$ |
2,395 |
|
|
$ |
5,654 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of Retrospective Application of New Accounting Standard
The retrospective application of the accounting standard resulted in the following adjustments
to our condensed consolidated balance sheet as of June 30, 2009 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounting |
|
|
|
|
|
|
As |
|
|
Standard |
|
|
As |
|
|
|
Reported |
|
|
Impact |
|
|
Revised |
|
Other assets |
|
$ |
25,343 |
|
|
$ |
(71 |
) |
|
$ |
25,272 |
|
Total assets |
|
|
376,221 |
|
|
|
(71 |
) |
|
|
376,150 |
|
Current deferred tax liability |
|
|
9,419 |
|
|
|
806 |
|
|
|
10,225 |
|
Note payable |
|
|
65,303 |
|
|
|
(2,069 |
) |
|
|
63,234 |
|
Total current liabilities |
|
|
136,323 |
|
|
|
(1,263 |
) |
|
|
135,060 |
|
Additional paid in capital |
|
|
270,962 |
|
|
|
22,704 |
|
|
|
293,666 |
|
Retained earnings |
|
|
187,666 |
|
|
|
(21,512 |
) |
|
|
166,154 |
|
Total stockholders equity |
|
|
221,414 |
|
|
|
1,192 |
|
|
|
222,606 |
|
Total liabilities and stockholders equity |
|
|
376,221 |
|
|
|
(71 |
) |
|
|
376,150 |
|
13
The retrospective application of the accounting standard resulted in the following adjustments
to our condensed consolidated income statement, basic and diluted net income per share, and
effective tax rate for the three and nine months ended March 31, 2009 (in thousands, except per
share data and effective tax rate):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, 2009 |
|
|
March 31, 2009 |
|
|
|
|
|
|
|
Accounting |
|
|
|
|
|
|
|
|
|
|
Accounting |
|
|
|
|
|
|
As |
|
|
Standard |
|
|
As |
|
|
As |
|
|
Standard |
|
|
As |
|
|
|
Reported |
|
|
Impact |
|
|
Revised |
|
|
Reported |
|
|
Impact |
|
|
Revised |
|
Interest expense |
|
$ |
(234 |
) |
|
$ |
(1,140 |
) |
|
$ |
(1,374 |
) |
|
$ |
(1,004 |
) |
|
$ |
(4,650 |
) |
|
$ |
(5,654 |
) |
Gain/(Loss) on early retirement of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,600 |
|
|
|
(4,653 |
) |
|
|
(1,053 |
) |
Provision for taxes |
|
|
(1,959 |
) |
|
|
460 |
|
|
|
(1,499 |
) |
|
|
(9,726 |
) |
|
|
3,753 |
|
|
|
(5,973 |
) |
Net income |
|
|
6,086 |
|
|
|
(680 |
) |
|
|
5,406 |
|
|
|
41,242 |
|
|
|
(5,550 |
) |
|
|
35,692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.18 |
|
|
$ |
(0.02 |
) |
|
$ |
0.16 |
|
|
$ |
1.22 |
|
|
$ |
(0.17 |
) |
|
$ |
1.05 |
|
Diluted |
|
$ |
0.17 |
|
|
$ |
(0.02 |
) |
|
$ |
0.15 |
|
|
$ |
1.17 |
|
|
$ |
(0.16 |
) |
|
$ |
1.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
|
24.4 |
% |
|
|
-2.7 |
% |
|
|
21.7 |
% |
|
|
19.1 |
% |
|
|
-4.8 |
% |
|
|
14.3 |
% |
The retrospective application of the accounting standard resulted in the following adjustments
to our condensed consolidated statement of cash flows for the nine months ended March 31, 2009 (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounting |
|
|
|
|
|
|
As |
|
|
Standard |
|
|
As |
|
|
|
Reported |
|
|
Impact |
|
|
Revised |
|
Net income |
|
$ |
41,242 |
|
|
$ |
(5,550 |
) |
|
$ |
35,692 |
|
Amortization of debt issuance costs |
|
|
465 |
|
|
|
(167 |
) |
|
|
298 |
|
Deferred taxes |
|
|
(5,818 |
) |
|
|
(3,753 |
) |
|
|
(9,571 |
) |
Amortization of debt discount |
|
|
|
|
|
|
4,817 |
|
|
|
4,817 |
|
9. Share-Based Compensation
The purpose of our various share-based compensation plans is to attract, motivate, retain, and
reward high-quality employees, directors, and consultants by enabling such persons to acquire or
increase their proprietary interest in our common stock in order to strengthen the mutuality of
interests between such persons and our stockholders and to provide such persons with annual and
long-term performance incentives to focus their best efforts in the creation of stockholder value.
Consequently, share-based compensatory awards issued subsequent to the initial award to our
employees and consultants are determined primarily on individual performance. Our share-based
compensation plans with outstanding awards consist of our 1996 Stock Option Plan, our 2000
Nonstatutory Stock Option Plan, our 2001 Incentive Compensation Plan, as amended, and our 2001
Employee Stock Purchase Plan, as amended.
Adjustments to Share-based Compensation Expense
During the second quarter of fiscal 2010 and in connection with an upgrade of the third-party
equity accounting software we use to determine share-based compensation expense, we discovered a
calculation error that affected our previously reported share-based compensation expense. The
previous software version incorrectly applied a weighted average forfeiture rate to each vest date
through the final vest date of each share-based award after which any shortfall in expense was
trued up, rather than true up any shortfall in expense on each vest date of each share-based award.
The impact of this incorrect calculation method to our share-based compensation expense was to
defer a portion of the expense recognition until the final vest date, which resulted in an
overstatement of net income of $569,000, $1.2 million, $1.1 million, and $165,000 for the fiscal
years 2006, 2007, 2008, and 2009, respectively, and $74,000 for the quarter ended September 30,
2009.
To correct the error, the financial statements for the three-month period ended December 31,
2009 includes a cumulative adjustment reducing net income by $3.1 million, or $0.09 per diluted
share. The tax benefit associated with the adjustment was $1.4 million and included tax benefit
from deferred stock units (DSUs) and non-qualified stock options, and no tax benefit from stock
compensation expense for qualified stock options. We reviewed the financial statement impact of
this error and concluded the impact is immaterial to our consolidated financial statements of prior
reporting periods, the three-period ended December 31, 2009, and the estimated annual financial
statements for the year ending June 30, 2010.
14
As noted above, we determined the cumulative error from the understatement of share-based
compensation expense related to prior periods was $3.1 million after tax. The additional expense
reported for the three- and six-month periods ended December 31, 2009 was $267,000 for cost of
revenue, $1.5 million for research and development, and $2.7 million for selling, general, and
administrative, partially offset by $1.4 million of additional tax benefit.
Share-based compensation and the related tax benefit recognized in our consolidated statements
of income for the three- and nine-month periods ended March 31, 2010 and 2009 were as follows (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
Cost of revenue |
|
$ |
553 |
|
|
$ |
437 |
|
|
$ |
1,816 |
|
|
$ |
1,250 |
|
Research and development |
|
|
3,328 |
|
|
|
2,295 |
|
|
|
10,772 |
|
|
|
6,273 |
|
Selling, general, and administrative |
|
|
4,314 |
|
|
|
3,371 |
|
|
|
14,751 |
|
|
|
10,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
8,195 |
|
|
$ |
6,103 |
|
|
$ |
27,339 |
|
|
$ |
17,640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax benefit recorded on share-based compensation |
|
$ |
1,735 |
|
|
$ |
1,712 |
|
|
$ |
7,042 |
|
|
$ |
5,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We utilize the Black-Scholes option pricing model to estimate the grant date fair value of
certain employee share-based compensatory awards, which requires the input of highly subjective
assumptions, including expected volatility and expected life. Historical and implied volatilities
were used in estimating the fair value of our share-based awards, while the expected life of our
options and estimated forfeitures for shared-based awards that are not expected to vest were
estimated based on historical trends since our initial public offering. Changes in these inputs
and assumptions can materially affect the measure of estimated fair value of our share-based
compensation. We charge the estimated fair value less estimated forfeitures to earnings on a
straight-line basis over the vesting period of the underlying awards, which is generally four years
for our stock options and deferred stock units and up to two years for our employee stock purchase
plan. The Black-Scholes option pricing model was developed for use in estimating the fair value of
traded options having no vesting restrictions and being fully transferable. As our stock option
and employee stock purchase plan awards have characteristics that differ significantly from traded
options and, as changes in the subjective assumptions can materially affect the estimated value,
our estimate of fair value may not accurately represent the value assigned by a third party in an
arms-length transaction. While our estimate of fair value and the associated charge to earnings
materially affects our results of operations, it has no impact on our cash position.
In accordance with U.S. GAAP, we recognize tax benefit upon expensing certain share-based
awards associated with our share-based compensation plans, including nonqualified stock options and
deferred stock units, but we cannot recognize tax benefit concurrent with the recognition of
share-based compensation expenses associated with incentive stock options and employee stock
purchase plan shares (qualified stock options). For qualified stock options that vested after we
began expensing share-based compensation, we recognize tax benefit only in the period when
disqualifying dispositions of the underlying stock occur, which historically has been up to several
years after vesting and in a period when our stock price substantially increases. For qualified
stock options that vested prior to when we began expensing share-based compensation, we record the
tax benefit directly to additional paid-in capital.
We determine excess tax benefit using the long-haul method in which we compare the actual tax
benefit associated with the tax deduction from share-based award activity to the hypothetical tax
benefit on the grant date fair values of the corresponding share-based awards. Tax benefit
associated with excess tax deduction creditable to additional paid-in capital is not recognized
until the deduction reduces taxes payable. During the nine-month periods ended March 31, 2010 and
March 31, 2009, we recognized $5.3 million and $6.1 million, respectively, of tax benefit as
additional paid-in capital.
Historically, we have issued new shares in connection with our share-based compensation plans;
however, treasury shares were also available for issuance as of March 31, 2010. Any additional
shares repurchased under our stock repurchase program would be available for issuance under our
share-based compensation plans.
15
Stock Options
Our share-based compensation plans with outstanding stock option awards include our 1996 Stock
Option Plan, our 2000 Nonstatutory Stock Option Plan, and our 2001 Incentive Compensation Plan, as
amended (the Plans). Under the Plans, we may grant employees, consultants, and directors
incentive stock options or nonqualified stock options to purchase shares of our common stock at not
less than 100% or 85% of the fair market value, respectively, on the date of grant. Stock options
granted to our employees generally are incentive stock options, or qualified options under the
Internal Revenue Code, subject to calendar year vesting limitations with any balance being
nonqualified stock options.
The following table summarizes stock option activity and weighted average exercise prices for
the nine months ended March 31, 2010, and for options outstanding and options exercisable, the
weighted average exercise prices and the
aggregate intrinsic value as of March 31, 2010. The aggregate intrinsic value is based on
the closing price of our common stock on March 26, 2010 and excludes stock options with exercise
prices above the closing price of $25.40.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
|
Weighted |
|
|
Aggregate |
|
|
|
Option |
|
|
Average |
|
|
Intrinsic |
|
|
|
Awards |
|
|
Exercise |
|
|
Value |
|
|
|
Outstanding |
|
|
Price |
|
|
(thousands) |
|
Balance at June 30, 2009 |
|
|
6,770,312 |
|
|
$ |
20.86 |
|
|
|
|
|
Granted |
|
|
1,253,825 |
|
|
|
25.35 |
|
|
|
|
|
Exercised |
|
|
(226,798 |
) |
|
|
15.81 |
|
|
|
|
|
Forfeited |
|
|
(19,908 |
) |
|
|
23.88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2010 |
|
|
7,777,431 |
|
|
|
21.72 |
|
|
$ |
39,976 |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2010 |
|
|
4,248,464 |
|
|
$ |
18.40 |
|
|
$ |
34,127 |
|
|
|
|
|
|
|
|
|
|
|
|
Options issued under the Plans generally vest 25% at the end of 12 months from the vesting
commencement date and approximately 2% each month thereafter until fully vested at the end of 48
months from the vesting commencement date. Options not exercised ten years after the date of grant
are cancelled.
Deferred Stock Units
Our 2001 Incentive Compensation Plan, as amended (2001 Plan), enables us to grant DSUs to
our employees, consultants, and directors. A DSU is a promise to deliver shares of our common
stock at a future date in accordance with the terms of the DSU grant agreement.
The following table summarizes DSU activity, including DSUs granted, delivered, and forfeited,
during the nine months ended March 31, 2010, and the balance and aggregate intrinsic value of DSUs
as of March 31, 2010.
|
|
|
|
|
|
|
|
|
|
|
Deferred |
|
|
Aggregate |
|
|
|
Stock Unit |
|
|
Intrinsic |
|
|
|
Awards |
|
|
Value |
|
|
|
Outstanding |
|
|
(thousands) |
|
Balance at June 30, 2009 |
|
|
738,258 |
|
|
|
|
|
Granted |
|
|
343,073 |
|
|
|
|
|
Delivered |
|
|
(220,284 |
) |
|
|
|
|
Forfeited |
|
|
(32,374 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2010 |
|
|
828,673 |
|
|
$ |
21,048 |
|
|
|
|
|
|
|
|
|
The aggregate intrinsic value is based on the closing price of our common stock on March 26,
2010 of $25.40.
Of the shares delivered, 66,092 shares valued at $1.6 million were withheld to meet statutory
minimum tax withholding requirements.
DSUs granted under the 2001 Plan generally vest 25% at the end of 12 months from the vesting
commencement date and at a rate of approximately 6% each quarter thereafter until fully vested at
the end of four years from the vesting commencement date. Delivery of shares under the plan takes
place on the quarterly vesting dates. At the delivery date, we withhold shares to cover statutory
minimum tax withholding by delivering a net number of shares. Until delivery of shares, the
grantee has no rights as a stockholder.
16
Employee Stock Purchase Plan
Our 2001 Employee Stock Purchase Plan, as amended (ESPP), became effective on January 29,
2002, the effective date of the registration statement for our initial public offering. The ESPP
allows employees to designate up to 15% of their base compensation, subject to legal restrictions
and limitations, to purchase shares of common stock at 85% of the lesser of the fair market value
(FMV) at the beginning of the offering period or the exercise date. The offering period extends
for up to two years and includes four exercise dates occurring at six month intervals. Under the
terms of
the plan, if the FMV at an exercise date is less than the FMV at the beginning of the offering
period, the current offering period will terminate and a new two-year offering period will
commence.
The following table summarizes the shares purchased, weighted average purchase price, cash
received, and the aggregate intrinsic value for ESPP purchases during the nine-month period ended
March 31, 2010 (in thousands, except for shares purchased and weighted average purchase price):
|
|
|
|
|
Shares purchased |
|
|
301,215 |
|
Weighted average purchase price |
|
$ |
15.15 |
|
Cash received |
|
$ |
4,562 |
|
Aggregate intrinsic value |
|
$ |
5,901 |
|
In accordance with U.S. GAAP, the early termination of an offering period followed by the
commencement of a new offering period represents a modification to the terms of the underlying
awards. Under the terms of our ESPP, the offering period that commenced on July 1, 2007 was
terminated on December 31, 2008 and a new offering period commenced on January 1, 2009. The
December 31, 2008 modification affected approximately 257 employees. The modification resulted in
incremental compensation costs, which are not material and which will be recognized on a
straight-line basis over the two-year period ending December 31, 2010.
10. Income Taxes
We account for income taxes under the asset and liability method. We consider the operating
earnings of our foreign subsidiaries to be indefinitely invested outside the United States.
Accordingly, no provision has been made for the U.S. federal, state, or foreign taxes that may
result from future remittances of undistributed earnings of our foreign subsidiaries.
The provision for income taxes of $45,000 and $1.5 million for the three months ended March
31, 2010 and 2009, respectively, represented estimated federal, foreign, and state taxes. The
effective tax rate for the three months ended March 31, 2010 was 0.4% and diverged from the
combined federal and state statutory rate primarily because of increased foreign income taxed at
lower tax rates, the recognition of tax benefit on the carryback of a prior year net operating
loss, the release of unrecognized tax benefits, and the benefit of research tax credits, partially
offset by foreign withholding taxes and net unrecognized tax benefit associated with qualified
stock options. We recorded a tax benefit of $1.8 million from the carryback of a prior year net
operating loss, which represents a revision of tax benefits generated in fiscal years 2008 and
2009. The effective tax rate for the three months ended March 31, 2009 was 21.7% and diverged from
the combined federal and state statutory rate primarily as a result of increased foreign income
taxed at lower tax rates, net recognized tax benefit associated with qualified stock options, the
benefit of research tax credits, and the impact of tax-exempt interest income, partially offset by
foreign withholding taxes, net unrecognized tax benefit associated with qualified stock options,
and the impairment of an investment for which a valuation allowance was established.
The provision for income taxes of $5.1 million and $6.0 million for the nine months ended
March 31, 2010 and 2009, respectively, represented estimated federal, foreign, and state taxes.
The effective tax rate for the nine months ended March 31, 2010 was 13.3% and diverged from the
combined federal and state statutory rate primarily because of increased foreign income taxed at
lower tax rates, the recognition of tax benefit on the carryback of a prior year net operating
loss, the release of unrecognized tax benefits, and the benefit of research tax credits, partially
offset by foreign withholding taxes, net unrecognized tax benefit associated with qualified stock
options, the impairment of an investment for which a full valuation allowance was established, and
the establishment of a valuation allowance on certain deferred tax assets. The effective tax rate
for the nine months ended March 31, 2009 was 14.3% and diverged from the combined federal and state
statutory rate primarily as a result of increased foreign income taxed at lower tax rates, net
recognized tax benefit associated with qualified stock options, the benefit of research tax
credits, and the impact of tax-exempt interest income, partially offset by foreign withholding
taxes, net unrecognized tax benefit associated with qualified stock options, and the impairment of
an investment for which a valuation allowance was established.
17
Unrecognized Tax Benefits
The total liability for gross unrecognized tax benefits decreased $218,000 during the quarter
ended March 31, 2010 to $18.2 million from $18.4 million at December 31, 2009 and resulted in a tax
rate benefit. The remaining liability for gross unrecognized tax benefit, if recognized, would
further reduce the effective tax rate on income from continuing
operations. The net decrease of $218,000 consisted of an increase of $1.2 million from current
and prior year tax positions, and a decrease of $1.4 million related to a statute expiration on
prior year tax positions. The total interest and penalties accrued related to unrecognized tax
benefits at March 31, 2010 of $1.1 million remained unchanged from the quarter ended December 31,
2009. We classify interest and penalties, if any, as components of income tax expense.
No material unrecognized tax benefit is expected to be paid within one year, and we cannot
make a reliable estimate when cash settlement with a taxing authority may occur. Any prospective
adjustments to our unrecognized tax benefits will be recorded as an increase or decrease to income
tax expense and cause a corresponding change to our effective tax rate. Accordingly, our effective
tax rate could fluctuate materially from period to period.
It is reasonably possible that the amount of the liability for unrecognized tax benefits may
change within the next 12 months. An estimate of the range of possible changes cannot be made at
this time because of the high uncertainty of the resolution of our tax positions with the various
tax jurisdictions in which we operate. Accordingly, the unrecognized tax benefits from prior year
tax positions that may be necessary to accrue or reverse for the next 12 months cannot be
reasonably estimated at this time.
Currently, we are required to file federal and state income tax returns in the United States
and foreign tax jurisdictions in which we operate. Our major tax jurisdictions are the United
States, California, and Hong Kong SAR and fiscal 2002 onward remain subject to examination by one
or more of these jurisdictions. In September 2007, we were notified by the state of California
Franchise Tax Board that our fiscal 2004 and 2005 returns were subject to audit, and in June 2009
we were notified by the Franchise Tax Board that the audit would be submitted for final approval
without adjustment. In January 2010, we settled with the Inland Revenue Department of Hong Kong on
all additional assessments and penalties related to prior year tax returns; however, tax returns
from fiscal 2004 onward remain subject to examination.
The federal research tax credit expired December 31, 2009. In the past, the federal research
credit has expired and has been retroactively reinstated. It is not clear if the research credit
will be retroactively reinstated or reinstated at all. If the research credit is not reinstated,
our tax rate in future periods will be negatively impacted.
During this quarter, President Obama signed into law the Patient Protection and Affordable
Care Act, the Health Care and Reconciliation Act of 2010, and the Hiring Incentives to Restore
Employment Act. We are currently evaluating the potential impact of these laws, but generally
believe they will increase our cost of operations.
11. Segment, Customers, and Geographic Information
We operate in one segment: the development, marketing, and sale of custom-designed capacitive
interface solutions that enable people to interact more easily and intuitively with a wide variety
of electronic devices and products. We generate our revenue from two broad product categories:
the PC market and digital lifestyle product markets. The PC market accounted for 63% and 51% of
net revenue for the three months ended March 31, 2010 and 2009, respectively, and 60% and 57% of
net revenue for the nine months ended March 31, 2010 and 2009, respectively.
18
The following is a summary of net revenue from sales to unaffiliated customers within
geographic areas based on the customer location (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
China |
|
$ |
81,760 |
|
|
$ |
74,875 |
|
|
$ |
285,744 |
|
|
$ |
233,542 |
|
Taiwan |
|
|
18,895 |
|
|
|
4,734 |
|
|
|
32,712 |
|
|
|
40,457 |
|
Korea |
|
|
8,459 |
|
|
|
12,352 |
|
|
|
25,814 |
|
|
|
49,984 |
|
Japan |
|
|
6,741 |
|
|
|
6,295 |
|
|
|
24,325 |
|
|
|
25,126 |
|
Other |
|
|
357 |
|
|
|
2,339 |
|
|
|
532 |
|
|
|
8,866 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
116,212 |
|
|
$ |
100,595 |
|
|
$ |
369,127 |
|
|
$ |
357,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following is major customer net revenue data as a percentage of net revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
Customer A |
|
|
12 |
% |
|
|
* |
|
|
|
* |
|
|
|
* |
|
Customer B |
|
|
10 |
% |
|
|
* |
|
|
|
11 |
% |
|
|
* |
|
Customer C |
|
|
* |
|
|
|
24 |
% |
|
|
* |
|
|
|
15 |
% |
Customer D |
|
|
* |
|
|
|
10 |
% |
|
|
* |
|
|
|
10 |
% |
We sell our products primarily to contract manufacturers that provide manufacturing services
to OEMs. We extend credit based on an evaluation of a customers financial condition, and we
generally do not require collateral. The following is major customer accounts receivable as a
percentage of accounts receivable:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
March 31, |
|
|
June 30, |
|
|
|
2010 |
|
|
2009 |
|
Customer A |
|
|
16 |
% |
|
|
* |
|
Customer B |
|
|
15 |
% |
|
|
11 |
% |
Customer C |
|
|
* |
|
|
|
20 |
% |
Customer D |
|
|
* |
|
|
|
11 |
% |
Customer E |
|
|
* |
|
|
|
10 |
% |
12. Comprehensive Income
Our comprehensive income generally consists of net income plus the effect of unrealized gains
and losses on our investments primarily due to changes in market value of certain of our ARS and
interest rate fluctuations on our fixed interest rate investments. In addition, we recognize the
noncredit portion of other-than-temporary impairment in comprehensive income. We recognize
remeasurement adjustments in our consolidated statement of income as the U.S. dollar is the
functional currency of our foreign entities.
19
Our comprehensive income for the three and nine months ended March 31, 2010 and 2009 is as
follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
|
Net income |
|
$ |
11,606 |
|
|
$ |
5,406 |
|
|
$ |
33,637 |
|
|
$ |
35,692 |
|
Net unrealized gain/ (loss) on available-for-sale
investments, net of tax |
|
|
(11 |
) |
|
|
3,335 |
|
|
|
1,575 |
|
|
|
2,974 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
$ |
11,595 |
|
|
$ |
8,741 |
|
|
$ |
35,212 |
|
|
$ |
38,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We recorded an unrealized loss of $11,000 and an unrealized gain of $1.6 million for the three
and nine months ended March 31, 2010, respectively, primarily related to the temporary recovery in
fair value of certain ARS investments.
13. Recent Accounting Pronouncements
In June 2009, the FASB issued SFAS No. 168, The FASB Accounting Standards
CodificationTM and the Hierarchy of Generally Accepted Accounting Principles, a
replacement of FASB Statement No. 162 (the Codification). The Codification, which was launched
on July 1, 2009, became the single source of authoritative nongovernmental U.S. GAAP, superseding
existing FASB, American Institute of Certified Public Accountants (AICPA), Emerging Issues Task
Force (EITF), and related literature. The Codification eliminates the GAAP hierarchy contained in
SFAS No. 162 and establishes one level of authoritative GAAP. All other literature is considered
non-authoritative. The Codification is effective for financial statements issued for interim and
annual periods ending after September 15, 2009. We adopted the Codification in our quarter ended
September 30, 2009.
In January 2010, the FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures
(ASC Topic 820) Improving Disclosures About Fair Value Measurements. The ASU requires new
disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about
purchases, sales, issuances, and settlements relating to Level 3 measurements. It also clarifies
existing fair value disclosures about the level of disaggregation and about inputs and valuation
techniques used to measure fair value. The new disclosures and clarifications of existing
disclosures were adopted in our quarter ended March 31, 2010, except for the disclosures about
purchases, sales, issuances, and settlements relating to Level 3 measurements, which will be
effective fiscal 2012. Other than requiring additional disclosures, the adoption of this new
guidance did not have a material impact on our consolidated financial position, results of
operations, or cash flows.
14. Subsequent Events
In April 2010, our Board of Directors approved an additional $100 million for the stock
repurchase program, expiring in April 2012, bringing the cumulative authorization to $420 million.
The remaining $38.1 million under the stock repurchase program, which was set to expire in July
2010 was extended, such that $138.1 million is now available for the repurchase of our common stock
through April 2012.
We have evaluated all events or transactions that occurred after March 31, 2010 through the
date of filing this report and determined there were no material recognizable subsequent events.
20
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements and Factors That May Affect Results
You should read the following discussion and analysis in conjunction with our condensed
consolidated financial statements and notes in Item 1 and with our audited consolidated financial
statements and notes included in our Annual Report on Form 10-K for the year ended June 30, 2009.
In addition to the historical information contained in this report, this report contains
forward-looking statements, including those related to our operating model and strategies; our
market penetration and market share in the notebook and digital lifestyle product markets;
competition factors in the notebook and digital lifestyle product markets; revenue from the
notebook and digital lifestyle product markets; industry estimates of growth rates of these
markets; average selling prices; product design mix; manufacturing costs; cost-improvement
programs; gross margins; customer relationships; research and development expenses; selling,
general, and administrative expenses; liquidity and anticipated cash requirements; and our ability
to provide local sales, operational, and engineering support to customers. These forward-looking
statements involve risks and uncertainties that could cause actual results to differ materially.
We caution that these statements are qualified by various factors that may affect future
results, including the following: economic conditions; changes in the market for our products and
the success of our customers products; our success in moving products from the design phase into
the manufacturing phase; changes in the competitive environment; infringement claims; warranty
obligations related to product failures; the failure of key technologies to deliver commercially
acceptable performance; our dependence on certain key markets; penetration into new markets; the
absence of both long-term purchase and supply commitments; and our lengthy development and product
acceptance cycles. This report should be read in conjunction with our Annual Report on Form 10-K
for the year ended June 30, 2009, including particularly Item 1A Risk Factors.
Overview
We are a leading worldwide developer and supplier of custom-designed capacitive interface
solutions that enable people to interact more easily and intuitively with a wide variety of mobile
computing, communications, entertainment, and other electronic devices. We believe our results to
date reflect the combination of our customer focus, the strength of our intellectual property, and
our engineering know-how, which allow us to develop or engineer products that meet the demanding
design specifications of OEMs.
Many of our customers have migrated their manufacturing operations from Taiwan to China, and
many of our OEM customers have established design centers in that region. With our expanded global
presence, including offices in China, Hong Kong, Japan, Korea, Switzerland, Taiwan, and the United
States, we are well positioned to provide local sales, operational, and engineering support
services to our existing customers, as well as potential new customers, on a global basis.
Our manufacturing operations are based on a variable cost model in which we outsource all of
our production requirements and generally drop ship our products directly to our customers from our
contract manufacturers facilities, eliminating the need for significant capital expenditures and
allowing us to minimize our investment in inventories. This approach requires us to work closely
with our contract manufacturers to ensure adequate production capacity to meet our forecasted
volume requirements. We provide our contract manufacturers with six-month rolling forecasts and
issue purchase orders based on our anticipated requirements for the next 90 days. However, we do
not have any long-term supply contracts with any of our contract manufacturers. We use three
third-party wafer manufacturers to supply wafers and two third-party packaging manufacturers to
package our proprietary ASICs. In certain cases, we rely on a single source or a limited number of
suppliers to provide other key components of our products. Our cost of revenue includes all costs
associated with the production of our products, including materials, logistics, manufacturing,
assembly, and test costs paid to third-party manufacturers and related overhead costs associated
with our indirect manufacturing operations personnel. Additionally, we charge all warranty costs,
yield losses, and any inventory provisions or write-downs to cost of revenue.
Our gross margin generally reflects the combination of the added value we bring to our OEM
customers products in meeting their custom design requirements and the impact of our ongoing
cost-improvement programs. These cost-improvement programs include reducing materials and
component costs and implementing design and process improvements. Our newly introduced products
may have lower margins than our more mature products, which have
realized greater benefits associated with our ongoing cost-improvement programs. As a result,
new product introductions may initially negatively impact our gross margin.
21
Our research and development expenses include personnel costs and supplies and materials costs
related to product development, as well as the engineering costs incurred to design capacitive
interface solutions for OEM customers prior to and after their commitment to incorporate those
solutions into their products. These expenses have generally increased, reflecting our continuing
commitment to the technological and design innovation required to maintain our position in our
existing markets and to adapt our existing technologies or develop new technologies for new
markets.
Selling, general, and administrative expenses include expenses related to sales, marketing,
and administrative personnel; internal sales and outside sales representatives commissions; market
and usability research; outside legal, accounting, and consulting costs; and other marketing and
sales activities. These expenses have generally increased, primarily reflecting incremental
staffing and related support costs associated with our increased business levels, growth in our
existing markets, and penetration into new markets.
Critical Accounting Policies and Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires us
to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue,
expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we
evaluate our estimates, including those related to revenue recognition, allowance for doubtful
accounts, cost of revenue, inventories, product warranty, provision for income taxes, income taxes
payable, intangible assets, and contingencies. We base our estimates on historical experience,
applicable laws, and various other assumptions that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Actual results may differ
from these estimates under different assumptions or conditions.
The methods, estimates, interpretations, and judgments we use in applying our most critical
accounting policies can have a significant impact on the results that we report in our consolidated
financial statements. The SEC considers an entitys most critical accounting policies to be those
policies that are both most important to the portrayal of the entitys financial condition and
results of operations and those that require the entitys most difficult, subjective, or complex
judgments, often as a result of the need to make estimates about matters that are inherently
uncertain when estimated. We believe the following critical accounting policies affect our more
significant judgments and estimates used in the preparation of our consolidated financial
statements.
Revenue Recognition
We recognize revenue from product sales when there is persuasive evidence that an arrangement
exists, delivery has occurred or title has transferred, the price is fixed or determinable, and
collection is reasonably assured. We accrue for estimated sales returns and other allowances,
based on historical experience, at the time we recognize revenue. We record contract revenue for
research and development as we provide the services under the terms of the contract. We recognize
non-refundable contract fees for which no further performance obligations exist and for which there
is no continuing involvement by us on the earlier of when the payments are received or when
collection is assured.
Investments
We account for investment securities in accordance with U.S. GAAP. The current accounting
standards require us to record available-for-sale securities at fair value, with non-credit related
unrealized gains and losses being reported as a component of other comprehensive income; to assess
whether our investments with loss positions are other-than-temporarily impaired; and to determine
whether an impairment of debt securities is other-than-temporary. We follow the hierarchal approach
to determine fair value of our investments, which we adopted at the beginning of fiscal 2009.
Fair value is defined as the price to be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at the measurement date. Our fair
value estimates consider, among other factors, the collateral underlying the security investments,
creditworthiness of the counterparty, timing of expected future cash flows, and, in the case of
ARS, the probability of a successful auction in a future period. We follow the guidance provided by
current accounting standards to estimate fair value when the volume and level of activity for an
asset or liability have significantly decreased in relation to normal market activity for the asset
or liability, and to determine circumstances that may indicate that a transaction is not orderly.
22
Further, we use judgment in evaluating whether a decline in fair value is temporary or
other-than-temporary and consider the following indicators: changes in credit ratings or asset
quality; changes in the economic environment; length
of time and extent to which fair value has been below cost basis; changes in market
conditions; changes in expected cash flows; and our ability and intent to hold the investment for a
period of time that may be sufficient for anticipated recovery in market value. Temporary declines
in fair value are recorded as charges to accumulated other comprehensive income in the equity
section of our balance sheet, while other-than-temporary declines in fair value are bifurcated
between credit losses, which are charged to earnings, and noncredit losses, which depending on
facts and circumstances may be charged to other comprehensive income or earnings.
Inventory
We state our inventories at the lower of cost or market. We base our assessment of the
ultimate realization of inventories on our projections of future demand and market conditions.
Sudden declines in demand, rapid product improvements, or technological changes, or any combination
of these factors can cause us to have excess or obsolete inventories. On an ongoing basis, we
review for estimated obsolete or unmarketable inventories and write down our inventories to their
net realizable value based upon our forecasts of future demand and market conditions. If actual
market conditions are less favorable than our forecasts, additional inventory write-downs may be
required. The following factors influence our estimates: changes to or cancellations of customer
orders, unexpected decline in demand, rapid product improvements and technological advances, and
termination or changes by our OEM customers of any product offerings incorporating our product
solutions.
Periodically, we purchase inventory from our contract manufacturers when a customer delays its
delivery schedule or cancels its order. In those circumstances in which our customer has cancelled
its order and we purchase inventory from our contract manufacturers, we consider a write-down to
reduce the carrying value of the inventory purchased to its net realizable value. We charge
write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to net
realizable value to cost of revenue. The effect of these write-downs is to establish a new cost
basis in the related inventory, which we do not subsequently write up.
Share-Based Compensation Costs
We utilize the Black-Scholes option pricing model to estimate the grant date fair value of
employee share-based compensatory awards, which requires the input of highly subjective
assumptions, including expected volatility and expected life. Historical and implied volatilities
were used in estimating the fair value of our share-based awards, while the expected life for our
options and estimated forfeitures for share-based awards that are not expected to vest were
estimated based on historical trends since our initial public offering. Changes in these inputs
and assumptions can materially affect the measure of estimated fair value of our share-based
compensation. We charge the estimated fair value less estimated forfeitures to earnings on a
straight-line basis over the vesting period of the underlying awards, which is generally four years
for our stock options and deferred stock units and up to two years for our employee stock purchase
plan.
The Black-Scholes option pricing model was developed for use in estimating the fair value of
traded options that have no vesting restrictions and are fully transferable. As our stock option
and employee stock purchase plan awards have characteristics that differ significantly from traded
options, and as changes in the subjective assumptions can materially affect the estimated value,
our estimate of fair value may not accurately represent the value assigned by a third party in an
arms-length transaction. There currently is no market-based mechanism to verify the reliability
and accuracy of the estimates derived from the Black-Scholes option pricing model or other
allowable valuation models, and there is no means to compare and adjust the estimates to actual
values. While our estimate of fair value and the associated charge to earnings materially affects
our results of operations, it has no impact on our cash position.
There are significant variations among allowable valuation models, and there is a possibility
that we may adopt a different valuation model or refine the inputs and assumptions under our
current valuation model in the future, resulting in a lack of consistency in future periods. Our
current or future valuation model and the inputs and assumptions we make may also lack
comparability to other companies that use different models, inputs, or assumptions, and the
resulting differences in comparability could be material.
Income Taxes
We recognize federal, foreign, and state current tax liabilities or assets based on our
estimate of taxes payable or refundable in the then current fiscal year for each tax jurisdiction.
We also recognize federal, foreign, and state deferred tax liabilities or assets for our estimate
of future tax effects attributable to temporary differences and carryforwards and record a
valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based
on available evidence and our judgment, are not expected to be realized. If our assumptions, and
consequently our estimates, change
in the future, the valuation allowance we have established for our deferred tax assets may be
changed, which could impact income tax expense.
23
We follow a two-step approach to recognizing and measuring uncertain tax positions. The first
step is to determine whether it is more-likely-than-not that a tax position will be sustained upon
examination, including resolution of any related appeals or litigation processes. The second step
is to measure the tax benefit as the largest amount that is more than 50% likely of being realized
upon ultimate settlement with a taxing authority. The calculation of tax liabilities involves
significant judgment in estimating the impact of uncertainties in the application of highly complex
tax laws. Resolution of these uncertainties in a manner inconsistent with our expectations could
have a material impact on our consolidated financial position, result of operations, or cash flows.
We believe we have adequately provided for reasonably foreseeable outcomes in connection with the
resolution of income tax uncertainties. However, our results have in the past, and could in the
future, include favorable and unfavorable adjustments to our estimated tax liabilities in the
period a determination of such estimated tax liability is made or resolved, upon the filing of an
amended return, upon a change in facts, circumstances, or interpretation, or upon the expiration of
a statute of limitation. Accordingly, our effective tax rate could fluctuate materially from
period to period.
We recognize tax benefit upon expensing nonqualified stock options and deferred stock units
issued under our share-based compensation plans. However, we cannot recognize tax benefit
concurrent with expensing incentive stock options and employee stock purchase plan shares
(qualified stock options) issued under our share-based compensation plans. For qualified stock
options that vested after we began expensing share-based compensation, we recognize tax benefit
only in the period when disqualifying dispositions of the underlying stock occur, which
historically has been up to several years after vesting and in periods when our stock price
substantially increases. For qualified stock options that vested prior to when we began expensing
share-based compensation, we record the tax benefit directly to additional paid-in capital.
Accordingly, because we cannot recognize the tax benefit for share-based compensation expense
associated with qualified stock options until the occurrence of future disqualifying dispositions
of the underlying stock and such disqualified dispositions may happen in periods when our stock
price substantially increases, and because a portion of that tax benefit may be directly recorded
to additional paid-in capital, our future quarterly and annual effective tax rates will be subject
to greater volatility and, consequently, our ability to estimate reasonably our future quarterly
and annual effective tax rates is greatly diminished.
24
Results of Operations
The following table sets forth our condensed consolidated results of operations for the
periods indicated, along with comparative information regarding the absolute and percentage changes
in these amounts (in thousands, except percentages):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Nine Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
$ Change |
|
|
% Change |
|
|
2010 |
|
|
2009 |
|
|
$ Change |
|
|
% Change |
|
|
PC applications |
|
$ |
72,936 |
|
|
$ |
50,758 |
|
|
$ |
22,178 |
|
|
|
43.7 |
% |
|
$ |
221,154 |
|
|
$ |
204,203 |
|
|
$ |
16,951 |
|
|
|
8.3 |
% |
Digital lifestyle product applications |
|
|
43,276 |
|
|
|
49,837 |
|
|
|
(6,561 |
) |
|
|
(13.2 |
%) |
|
|
147,973 |
|
|
|
153,772 |
|
|
|
(5,799 |
) |
|
|
(3.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
116,212 |
|
|
|
100,595 |
|
|
|
15,617 |
|
|
|
15.5 |
% |
|
|
369,127 |
|
|
|
357,975 |
|
|
|
11,152 |
|
|
|
3.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
47,302 |
|
|
|
40,707 |
|
|
|
6,595 |
|
|
|
16.2 |
% |
|
|
149,455 |
|
|
|
145,106 |
|
|
|
4,349 |
|
|
|
3.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
21,212 |
|
|
|
17,286 |
|
|
|
3,926 |
|
|
|
22.7 |
% |
|
|
63,629 |
|
|
|
49,031 |
|
|
|
14,598 |
|
|
|
29.8 |
% |
Selling, general, and administrative |
|
|
14,635 |
|
|
|
12,786 |
|
|
|
1,849 |
|
|
|
14.5 |
% |
|
|
44,974 |
|
|
|
41,070 |
|
|
|
3,904 |
|
|
|
9.5 |
% |
|
Income from operations |
|
|
11,455 |
|
|
|
10,635 |
|
|
|
820 |
|
|
|
7.7 |
% |
|
|
40,852 |
|
|
|
55,005 |
|
|
|
(14,153 |
) |
|
|
(25.7 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
200 |
|
|
|
538 |
|
|
|
(338 |
) |
|
|
(62.8 |
%) |
|
|
772 |
|
|
|
2,770 |
|
|
|
(1,998 |
) |
|
|
(72.1 |
%) |
Interest expense |
|
|
(4 |
) |
|
|
(1,374 |
) |
|
|
1,370 |
|
|
|
(99.7 |
%) |
|
|
(2,395 |
) |
|
|
(5,654 |
) |
|
|
3,259 |
|
|
|
(57.6 |
%) |
Loss on early retirement of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,053 |
) |
|
|
1,053 |
|
|
|
n/m |
(1) |
Impairment of investment, net |
|
|
|
|
|
|
(2,894 |
) |
|
|
2,894 |
|
|
|
n/m |
(1) |
|
|
(443 |
) |
|
|
(9,403 |
) |
|
|
8,960 |
|
|
|
(95.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
11,651 |
|
|
|
6,905 |
|
|
|
4,746 |
|
|
|
68.7 |
% |
|
|
38,786 |
|
|
|
41,665 |
|
|
|
(2,879 |
) |
|
|
(6.9 |
%) |
Provision for income taxes |
|
|
45 |
|
|
|
1,499 |
|
|
|
(1,454 |
) |
|
|
(97.0 |
%) |
|
|
5,149 |
|
|
|
5,973 |
|
|
|
(824 |
) |
|
|
(13.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
11,606 |
|
|
$ |
5,406 |
|
|
$ |
6,200 |
|
|
|
114.7 |
% |
|
$ |
33,637 |
|
|
$ |
35,692 |
|
|
$ |
(2,055 |
) |
|
|
(5.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth certain of our Condensed Consolidated Statements of Income data
as a percentage of revenues for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage |
|
|
|
|
|
|
|
|
|
|
Percentage |
|
|
|
Three Months Ended |
|
|
Point |
|
|
Nine Months Ended |
|
|
Point |
|
|
|
March 31, |
|
|
Increase |
|
|
March 31, |
|
|
Increase |
|
|
|
2010 |
|
|
2009 |
|
|
(Decrease) |
|
|
2010 |
|
|
2009 |
|
|
(Decrease) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PC applications |
|
|
62.8 |
% |
|
|
50.5 |
% |
|
|
12.3 |
% |
|
|
59.9 |
% |
|
|
57.0 |
% |
|
|
2.9 |
% |
Digital lifestyle product applications |
|
|
37.2 |
% |
|
|
49.5 |
% |
|
|
(12.3 |
%) |
|
|
40.1 |
% |
|
|
43.0 |
% |
|
|
(2.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
40.7 |
% |
|
|
40.5 |
% |
|
|
0.2 |
% |
|
|
40.5 |
% |
|
|
40.5 |
% |
|
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
18.3 |
% |
|
|
17.2 |
% |
|
|
1.1 |
% |
|
|
17.2 |
% |
|
|
13.7 |
% |
|
|
3.5 |
% |
Selling, general, and administrative |
|
|
12.6 |
% |
|
|
12.7 |
% |
|
|
(0.1 |
%) |
|
|
12.2 |
% |
|
|
11.5 |
% |
|
|
0.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
9.9 |
% |
|
|
10.6 |
% |
|
|
(0.7 |
%) |
|
|
11.1 |
% |
|
|
15.4 |
% |
|
|
(4.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
10.0 |
% |
|
|
6.9 |
% |
|
|
3.1 |
% |
|
|
10.5 |
% |
|
|
11.6 |
% |
|
|
(1.1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
0.0 |
% |
|
|
1.5 |
% |
|
|
(1.5 |
%) |
|
|
1.4 |
% |
|
|
1.7 |
% |
|
|
(0.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
10.0 |
% |
|
|
5.4 |
% |
|
|
4.6 |
% |
|
|
9.1 |
% |
|
|
10.0 |
% |
|
|
(0.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25
Net Revenue
Net revenue was $116.2 million for the quarter ended March 31, 2010 compared with $100.6
million for the quarter ended March 31, 2009, an increase of $15.6 million, or 15.5%. Of our third
quarter fiscal 2010 net revenue, $72.9 million, or 62.8%, was from personal computing products and
$43.3 million, or 37.2%, was from digital lifestyle products, including $42.0 million from mobile
smartphones. The increase in net revenue for the quarter ended March 31, 2010 was attributable to a
$22.2 million, or 43.7%, increase in net revenue from PC applications, partially offset by a
$6.6 million, or 13.2%, decrease in net revenue from digital lifestyle product applications
due to portable media players. The overall increase in net revenue was primarily attributable to a
31% increase in unit shipments reflecting higher market penetration of our products in the personal
computing and digital lifestyle markets, partially offset by lower priced product mix, general
competitive pricing pressure, and a reduced attach rate of our multimedia control solutions in
notebook computers.
Net revenue was $369.1 million for the nine months ended March 31, 2010 compared with $358.0
million for the nine months ended March 31, 2009, an increase of $11.2 million, or 3.1%. Of our
nine months fiscal 2010 net revenue, $221.1 million, or 59.9%, was from PC applications and $148.0
million, or 40.1%, was from digital lifestyle products applications, including $118.6 million from
mobile smartphones. The increase in net revenue for the nine months ended March 31, 2010 was
attributable to a $17.0 million, or 8.3%, increase in net revenue from PC applications, partially
offset by a $5.8 million, or 3.8%, decrease in net revenue from digital lifestyle product
applications due to portable media players. The overall increase in net revenue was primarily
attributable to a 19% increase in unit shipments, reflecting higher market penetration of our
products in the personal computing and digital lifestyle markets, partially offset by an overall
lower-priced product mix, general competitive pricing pressure, and a reduced attach rate of our
multimedia control solutions in notebook computers.
Based on calendar year 2010 industry estimates, the notebook market is anticipated to increase
approximately 21% and the mobile smartphone market is anticipated to increase approximately 28%
over 2009 levels.
Gross Margin
Gross margin as a percentage of net revenue was 40.7%, or $47.3 million, for the quarter ended
March 31, 2010 compared with 40.5%, or $40.7 million, for the quarter ended March 31, 2009. Gross
margin as a percentage of net revenue was 40.5%, or $149.5 million, for the nine months ended March
31, 2010 compared with 40.5%, or $145.1 million, for the nine months ended March 31, 2009.
As each custom-designed module we sell utilizes our capacitive sensing technology in a design
that is generally unique or specific to a customers application, gross margin varies on a
product-by-product basis, making our cumulative gross margin a blend of our product specific
designs and independent of the vertical markets that our products serve.
Adjustments to Share-based Compensation Expense
As described in note 9 of the notes to condensed consolidated financial statements, we
determined the cumulative error from the understatement of share-based compensation expense related
to prior periods was $3.1 million after tax. The additional expense reported for the three-month
period ended December 31, 2009 was $267,000 for cost of revenue, $1.5 million for research and
development, $2.7 million for selling, general, and administrative, partially offset by $1.4
million of additional tax benefit.
Operating Expenses
Research and Development Expenses. Research and development expenses increased as a
percentage of net revenue to 18.3% from 17.2%, while the cost of research and development
activities increased $3.9 million, or 22.7%, to $21.2 million for the three-month period ended
March 31, 2010 compared with $17.3 million for the three-month period ended March 31, 2009. The
increase in research and development expenses primarily reflected a $2.4 million increase in
employee compensation costs from our annual merit adjustments, additional staffing, and employee
benefits costs, and a $1.0 million increase in share-based compensation costs.
Research and development expenses increased as a percentage of net revenue from 13.7% to
17.2%, and the cost of research and development activities increased $14.6 million, or 29.8%, to
$63.6 million for the nine months ended March 31, 2010 compared with $49.0 million for the nine
months ended March 31, 2009. The increase in research and development expenses primarily reflected
a $7.6 million increase in employee compensation costs from additional staffing, our annual merit
adjustments, and employee benefits costs; a $4.5 million increase in share-based compensation
costs; and a $2.6 million increase in infrastructure and support costs.
Selling, General, and Administrative Expenses. Selling, general, and administrative expenses
increased to $14.6 million for the three-month period ended March 31, 2010 compared with $12.8
million for the three-month period ended March 31, 2009. The increase in selling, general, and
administrative expenses primarily reflected a $944,000 increase in share-based compensation costs,
a $532,000 increase in employee compensation costs from our annual merit
adjustments, additional staffing, higher employee benefits costs and greater recruiting costs,
as well as an increase of $284,000 of other costs primarily related to outside services.
26
Selling, general, and administrative expenses increased as a percentage of net revenue to
12.2% from 11.5%, while the cost of selling, general, and administrative activities increased $3.9
million, or 9.5%, to $45.0 million for the nine months ended March 31, 2010 compared with $41.1
million for the nine months ended March 31, 2009. The increase in selling, general, and
administrative expenses primarily reflected a $4.6 million increase in share-based compensation
costs, partially offset by a decrease in litigation costs resulting from the settlement of
litigation in the quarter ended December 31, 2008.
Income from Operations
We generated operating income of $11.5 million, or 9.9% of net revenue, for the three months
ended March 31, 2010 compared with approximately $10.6 million, or 10.6% of net revenue, for the
three months ended March 31, 2009. The increase in operating income primarily reflected our
increased operating levels, and a 20 basis point increase in the gross margin, partially offset by
a $5.8 million increase in operating expenses.
We generated operating income of $40.9 million, or 11.1% of net revenue, for the nine months
ended March 31, 2010 compared with $55.0 million, or 15.4% of net revenue, for the nine months
ended March 31, 2009. The decrease in operating income primarily reflected the $18.5 million
increase in operating expenses, partially offset by $4.3 million of gross margin generated from our
increased operating levels.
Non-Operating Income/(Loss)
Interest Income. Interest income was $200,000 for the three-month period ended March 31, 2010
compared with $538,000 for the three-month period ended March 31, 2009. Interest income was
$772,000 for the nine months ended March 31, 2010 compared with $2.8 million for the nine months
ended March 31, 2009. The decrease in interest income resulted from the combination of lower
interest rates and lower average invested cash balances.
Interest Expense. All of our interest expense related to our Notes issued in December 2004.
Interest expense was $4,000 for the three months ended March 31, 2010 compared with interest
expense of $1.4 million, of which $1.2 million represents debt issuance cost amortization, for the
three months ended March 31, 2009. During the quarter ended December 31, 2009, $63.0 million of
Notes were retired, leaving $2.3 million outstanding as of December 31, 2009 and March 31, 2010,
which caused the decrease in interest expense.
Interest expense was $2.4 million for the nine months ended March 31, 2010, which included a
$2.1 million non-cash charge for amortization of debt discount, compared with interest expense of
$5.7 million for the nine months ended March 31, 2009, which included a $4.8 million non-cash
charge for amortization of debt discount.
The non-cash charges for amortization of debt discount result from the retrospective
application of a new accounting standard applicable to convertible debt that can be settled in
cash. The remaining interest expense consists of coupon interest and amortization of debt issuance
costs. All debt discount and debt issuance costs were fully amortized as of December 31, 2009.
Provision for Income Taxes
We account for income taxes under the asset and liability method. We consider the operating
earnings of our foreign subsidiaries to be indefinitely invested outside the United States.
Accordingly, no provision has been made for the U.S. federal, state, or foreign taxes that may
result from future remittances of undistributed earnings of our foreign subsidiaries.
The provision for income taxes of $45,000 and $1.5 million for the three months ended March
31, 2010 and 2009, respectively, represented estimated federal, foreign, and state taxes. The
effective tax rate for the three months ended March 31, 2010 was 0.4% and diverged from the
combined federal and state statutory rate primarily because of increased foreign income taxed at
lower tax rates, the recognition of tax benefit on the carryback of a prior year net operating
loss, the release of unrecognized tax benefits, and the benefit of research tax credits, partially
offset by foreign withholding taxes and net unrecognized tax benefit associated with qualified
stock options. We recorded a tax benefit of $1.8 million from the carryback of a prior year net
operating loss, which represents a revision of tax benefits generated in fiscal years 2008 and
2009. The effective tax rate for the three months ended March 31, 2009 was 21.7% and diverged from
the combined federal and state statutory rate primarily as a result of increased foreign income
taxed at lower tax rates, net
recognized tax benefit associated with qualified stock options, the benefit of research tax
credits, and the impact of tax-exempt interest income, partially offset by foreign withholding
taxes, net unrecognized tax benefit associated with qualified stock options, and the impairment of
an investment for which a valuation allowance was established.
27
Tax benefit associated with share-based compensation was approximately $1.7 million for each
of the three months ended March 31, 2010 and 2009, respectively. Excluding the impact of
share-based compensation and the related tax benefit, the effective tax rate for the three months
ended March 31, 2010 and 2009 would have been 9.0% and 24.7%, respectively.
The provision for income taxes of $5.1 million and $6.0 million for the nine months ended
March 31, 2010 and 2009, respectively, represented estimated federal, foreign, and state taxes.
The effective tax rate for the nine months ended March 31, 2010 was 13.3% and diverged from the
combined federal and state statutory rate primarily because of increased foreign income taxed at
lower tax rates, the recognition of tax benefit on the carryback of a prior year net operating
loss, the release of unrecognized tax benefits, and the benefit of research tax credits, partially
offset by foreign withholding taxes, net unrecognized tax benefit associated with qualified stock
options, the impairment of an investment for which a full valuation allowance was established, and
the establishment of a valuation allowance on certain deferred tax assets. The effective tax rate
for the nine months ended March 31, 2009 was 14.3% and diverged from the combined federal and state
statutory rate primarily as a result of increased foreign income taxed at lower tax rates, net
recognized tax benefit associated with qualified stock options, the benefit of research tax
credits, and the impact of tax-exempt interest income, partially offset by foreign withholding
taxes, net unrecognized tax benefit associated with qualified stock options, and the impairment of
an investment for which a valuation allowance was established.
Tax benefit associated with share-based compensation was approximately $7.0 million and $5.4
million for the nine months ended March 31, 2010 and 2009, respectively. Excluding the impact of
share-based compensation and the related tax benefit, the effective tax rate for the nine months
ended March 31, 2010 and 2009 would have been 18.4% and 19.3%, respectively.
The federal research tax credit expired December 31, 2009. In the past, the federal research
credit has expired and has been retroactively reinstated. It is not clear if the research credit
will be retroactively reinstated or reinstated at all. If the research credit is not reinstated,
our tax rate in future periods will be negatively impacted.
During this quarter, President Obama signed into law the Patient Protection and Affordable
Care Act, the Health Care and Reconciliation Act of 2010, and the Hiring Incentives to Restore
Employment Act. We are currently evaluating the potential impact of these laws, but generally
believe they will increase our cost of operations.
28
Liquidity and Capital Resources
Our cash, cash equivalents, and short-term investments, which excludes ARS investments, were
$168.7 million as of March 31, 2010 compared with $192.0 million as of June 30, 2009, a decrease of
$23.3 million. The decrease primarily reflected $63.0 million used for the retirement of debt,
$44.5 million used for the repurchase of our common stock in the open market, and $6.3 million used
for the purchase of capital equipment, partially offset by $77.6 million provided from operating
cash flows and $8.1 million of proceeds from common stock issued under our share-based compensation
plans.
Cash Flows from Operating Activities. Operating activities during the nine months ended March
31, 2010 generated cash of approximately $77.6 million compared with approximately $75.4 million of
cash generated during the nine months ended March 31, 2009. For the nine months ended March 31,
2010, net cash provided by operating activities was primarily attributable to net income of $33.6
million plus adjustments for non-cash charges of $33.2 million, in addition to a $10.8 million net
increase in operating assets and liabilities. The net increase in operating assets and liabilities
was primarily attributable to a $16.0 million increase in accounts payable primarily as a result of
a favorable change in payment terms with certain suppliers, partially offset by changes in other
operating assets and liabilities. Our days sales outstanding increased slightly from 66 to 68 days
from June 30, 2009 to March 31, 2010 and our inventory turns declined from 18 to 15 days for the
same period. For the nine months ended March 31, 2009, net cash provided by operating activities
was primarily attributable to net income of $35.7 million plus adjustments for non-cash charges of
$28.1 million and an $11.6 million net decrease in operating assets and liabilities. The decrease
in operating assets and liabilities was primarily attributable to a $5.2 million decrease in
inventory, resulting from our efforts to manage inventories to lower levels.
Cash Flows from Investing Activities. Our investing activities typically relate to purchases
of government-backed securities and investment-grade fixed income instruments and purchases of
property and equipment. Investing activities during the nine months ended March 31, 2010 generated
net cash of $17.8 million compared with $16.2 million of net cash generated during the nine months
ended March 31, 2009. During the nine months ended March 31, 2010, net cash generated by investing
activities consisted of $28.9 million in proceeds from sales and maturities of short-term and $1.1
million from noncurrent investments, partially offset by $6.0 million used for the purchase of
short-term investments and $6.3 million used for the purchase of property and equipment. During
the nine months ended March 31, 2009, net cash generated by investing activities consisted of $42.9
million in proceeds from sales and maturities of short-term investments and $1.6 million from
noncurrent investments, partially offset by $21.0 million used for the purchase of short-term
investments and $7.3 million used for the purchase of property and equipment.
Cash Flows from Financing Activities. Net cash used in financing activities for the nine
months ended March 31, 2010 was approximately $95.7 million compared with $41.8 million net cash
used in financing activities for the nine months ended March 31, 2009. Cash used in financing
activities for the nine months ended March 31, 2010 was primarily related to $63.0 million for the
retirement of debt, $44.5 million for the purchase of our common stock in the open market, and $1.6
million used for the payment of payroll taxes for deferred stock units, partially offset by $8.1
million of proceeds from common stock issued under our share-based compensation plans and $5.3
million from the excess tax benefit from share-based compensation. Cash used in financing
activities for the nine months ended March 31, 2009 consisted primarily of $55.7 million for the
retirement of debt, $1.3 million used for the payment of payroll taxes for deferred stock units,
partially offset by $9.1 million in proceeds from common stock issued under our share-based
compensation plans, and $6.1 million from the excess tax benefit from share-based compensation.
Common Stock Repurchase Program. In April 2010, our board of directors authorized an
additional $100 million for our common stock repurchase program, increasing the cumulative
authorization to $420 million. The program authorizes us to purchase our common stock in the open
market or in privately negotiated transactions depending upon market conditions and other factors.
The number of shares repurchased and the timing of repurchases is based on the level of our cash
balances, general business and market conditions, and other factors, including alternative
investment opportunities. Common stock repurchased under this program is held as treasury stock.
From April 2005 through March 31, 2010, we repurchased 10,871,313 shares of our common stock in the
open market for an aggregate cost of $281.9 million. Of our treasury stock, 9,088,100 shares were
repurchased prior to the August 29, 2008 and were not subject to the 3-for-2 stock split. We
currently have $138.1 million available under our common stock repurchase program, which expires in
April 2012.
Bank Credit Facility. We currently maintain a $30.0 million unsecured working capital line of
credit with Wells Fargo Bank. The Wells Fargo Bank revolving line of credit, which expires on July
1, 2010, provides for an interest rate equal to the prime lending rate or 250 basis points above
LIBOR, depending on whether we choose a variable or fixed rate, respectively. We had not borrowed
any amounts under the line of credit as of March 31, 2010.
29
Convertible Senior Subordinated Notes. In December 2004, we issued an aggregate of $125
million of Notes maturing December 1, 2024 in a private offering pursuant to Rule 144A under the
Securities Act of 1933, as amended. In connection with issuing the Notes, we incurred debt
issuance costs of $4.3 million, consisting primarily of the initial purchasers discount and costs
related to legal, accounting, and printing. We have purchased and retired $122.7 million of the
Notes. The remaining $2.3 million of Notes outstanding as of March 31, 2010 have been classified
as long-term as the next date Noteholders can require us to repurchase all or a portion of the
Notes is beyond one year.
$250 Million Shelf Registration. We have registered an aggregate of $250 million of common
stock (including the associated rights), preferred stock, debt securities, depositary shares,
warrants, purchase contracts, and units (collectively securities) for issuance to raise funds for
general corporate purposes, which may include the repayment of indebtedness outstanding from time
to time, working capital, capital expenditures, acquisitions, and repurchases of our common stock
or other securities. Securities issued under the shelf registration generally will be freely
tradeable after their issuance unless held by an affiliate of our company, in which case such
shares will be subject to the volume and manner of sale restrictions of Rule 144.
$100 Million Shelf Registration. We have registered an aggregate of $100 million of common
stock and preferred stock for issuance in connection with acquisitions, which shares generally will
be freely tradeable after their issuance under Rule 145 of the Securities Act unless held by an
affiliate of the acquired company, in which case such shares will be subject to the volume and
manner of sale restrictions of Rule 144.
Liquidity and Capital Resources. We believe our existing cash, cash equivalents, and
short-term investment balances and anticipated cash flows from operating activities will be
sufficient to meet our working capital and other cash requirements over the course of at least the
next 12 months. Our future capital requirements will depend on many factors, including our rate of
revenue growth or decline, the timing and extent of spending to support product development
efforts, costs related to protecting our intellectual property, the expansion of sales and
marketing activities, the timing of introductions of new products and enhancements to existing
products, the costs to ensure access to adequate manufacturing capacity, the continuing market
acceptance of our product solutions, our common stock purchase program, and the amount and timing
of our investments in, or acquisitions of, other technologies or companies. Further equity or debt
financing may not be available to us on acceptable terms or at all. If sufficient funds are not
available or are not available on acceptable terms, our ability to take advantage of unexpected
business opportunities or to respond to competitive pressures could be limited or severely
constrained.
Our non-current investments consist of ARS investments, which have failed to settle in
auctions. These failures generally resulted in the interest rates resetting on the regularly
scheduled auction dates. These investments are not liquid, and in the event we need to access
these funds, we will not be able to do so without a loss of principal, unless redeemed by the
issuers or a future auction on these investments is successful. At March 31, 2010, the fair value
of our ARS investments was $28.8 million and had an original cost basis of $41.4 million. In the
first nine months of 2010, $1.1 million of our ARS investments were redeemed at par and we
recognized a gain of $6,000 on the redemption. In connection with our fair value analysis for the
nine months ended March 31, 2010, we recorded a $449,000 other-than-temporary impairment charge.
Based on our ability to access our cash and other short-term investments, our expected
operating cash flows, and our other sources of cash, we do not anticipate the lack of liquidity on
these investments will affect our ability to operate our business as usual.
30
Contractual Obligations and Commercial Commitments
The following table sets forth a summary of our material contractual obligations and
commercial commitments as of March 31, 2010 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments due by period |
|
|
|
|
|
|
|
Less than |
|
|
1-3 |
|
|
3-5 |
|
|
More than |
|
Contractual Obligations |
|
Total |
|
|
1 year |
|
|
Years |
|
|
Years |
|
|
5 Years |
|
Convertible senior subordinated notes (1) |
|
$ |
3 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3 |
|
Leases and other commitments |
|
|
13 |
|
|
|
9 |
|
|
|
3 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
16 |
|
|
$ |
9 |
|
|
$ |
3 |
|
|
$ |
1 |
|
|
$ |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents both principal and interest payable through the maturity date of the
underlying contractual obligation. |
As of March 31, 2010, we were unable to make a reasonably reliable estimate of when cash
settlement with a taxing authority may occur in connection with our unrecognized tax benefits of
$18.2 million.
Recent Accounting Pronouncements
In June 2009, the FASB issued SFAS No. 168, The FASB Accounting Standards
CodificationTM and the Hierarchy of Generally Accepted Accounting Principles, a
replacement of FASB Statement No. 162 (the Codification). The Codification, which was launched
on July 1, 2009, became the single source of authoritative nongovernmental U.S. GAAP, superseding
existing FASB, American Institute of Certified Public Accountants (AICPA), Emerging Issues Task
Force (EITF), and related literature. The Codification eliminates the GAAP hierarchy contained in
SFAS No. 162 and establishes one level of authoritative GAAP. All other literature is considered
non-authoritative. The Codification is effective for financial statements issued for interim and
annual periods ending after September 15, 2009. We adopted the Codification in our quarter ended
September 30, 2009.
In January 2010, the FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures
(ASC Topic 820) Improving Disclosures About Fair Value Measurements. The ASU requires new
disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about
purchases, sales, issuances, and settlements relating to Level 3 measurements. It also clarifies
existing fair value disclosures about the level of disaggregation and about inputs and valuation
techniques used to measure fair value. The new disclosures and clarifications of existing
disclosures were adopted in our quarter ended March 31, 2010, except for the disclosures about
purchases, sales, issuances, and settlements relating to Level 3 measurements, which will be
effective in fiscal 2012. Other than requiring additional disclosures, the adoption of this new
guidance did not have a material impact on our consolidated financial position, results of
operations, or cash flows.
31
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our market risk has not changed significantly from the interest rate and foreign currency
risks disclosed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 30,
2009.
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this report, our Chief Executive Officer and Chief
Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and
procedures, which included inquiries made to certain other of our employees. Based on their
evaluation, our Chief Executive Officer and Chief Financial Officer have each concluded that our
disclosure controls and procedures are designed and are effective to ensure that information
required to be disclosed is accumulated and communicated to our management, including our Chief
Executive Officer and Chief Financial Officer, to allow timely decisions regarding required
disclosure and are effective and sufficient to ensure that we record, process, summarize, and
report information required to be disclosed by us in our periodic reports filed under the
Securities Exchange Act within the time periods specified by the Securities and Exchange
Commissions rules and forms.
During the fiscal quarter covered by this report, there have not been any changes in our
internal control over financial reporting that have materially affected, or a reasonably likely to
materially affect, our internal control over financial reporting.
32
PART II OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
Our board of directors has cumulatively authorized $420 million for our common stock
repurchase program. The remaining amount authorized for the repurchase of our common stock is
$138.1 million. There were no repurchases under the stock repurchase program during the
three-month period ended March 31, 2010.
ITEM 6. EXHIBITS
|
|
|
|
|
|
31.1 |
|
|
Certification of Chief Executive Officer |
|
|
|
|
|
|
31.2 |
|
|
Certification of Chief Financial Officer |
|
|
|
|
|
|
32.1 |
|
|
Section 1350 Certification of Chief Executive Officer |
|
|
|
|
|
|
32.2 |
|
|
Section 1350 Certification of Chief Financial Officer |
33
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
SYNAPTICS INCORPORATED
|
|
Date: May 4, 2010 |
By: |
/s/ Thomas J. Tiernan
|
|
|
|
Name: |
Thomas J. Tiernan |
|
|
|
Title: |
President and Chief Executive Officer |
|
|
|
|
|
By: |
/s/ Kathleen A. Bayless
|
|
|
|
Name: |
Kathleen A. Bayless |
|
|
|
Title: |
Chief Financial Officer, Secretary, and Treasurer |
|
34
Exhibit 31.1
EXHIBIT 31.1
Certification of Chief Executive Officer
I, Thomas J. Tiernan, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Synaptics Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;
c) Evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and
d) Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
Date: May 4, 2010
|
|
|
|
|
|
/s/ Thomas J. Tiernan
|
|
|
Thomas J. Tiernan |
|
|
Chief Executive Officer |
|
Exhibit 31.2
EXHIBIT 31.2
Certification of Chief Financial Officer
I, Kathleen A. Bayless, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Synaptics Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
b) Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;
c) Evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and
d) Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
Date: May 4, 2010
|
|
|
|
|
|
/s/ Kathleen A. Bayless
|
|
|
Kathleen A. Bayless |
|
|
Chief Financial Officer |
|
Exhibit 32.1
EXHIBIT 32.1
Section 1350 Certification of Chief Executive Officer
In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the Company)
for the quarterly period ended March 27, 2010 as filed with the Securities and Exchange Commission
on the date hereof (the Report), I, Thomas J. Tiernan, Chief Executive Officer of the Company,
certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant
to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
(2) |
The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. |
|
|
|
/s/ Thomas J. Tiernan |
|
|
|
|
|
Chief Executive Officer |
|
|
May 4, 2010 |
|
|
Exhibit 32.2
EXHIBIT 32.2
Section 1350 Certification of Chief Financial Officer
In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the Company)
for the quarterly period ended March 27, 2010 as filed with the Securities and Exchange Commission
on the date hereof (the Report), I, Kathleen A. Bayless, Chief Financial Officer of the Company,
certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant
to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) |
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
(2) |
|
The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. |
|
|
|
/s/ Kathleen A. Bayless |
|
|
|
|
|
Chief Financial Officer |
|
|
May 4, 2010 |
|
|